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Abstract
MRI is sensitive to tissue pathology in multiple sclerosis (MS); however, most lesional MRI findings have limited correlation
with disability. Chronic T1 hypointense lesions or ‘‘T1 black holes’’ (T1BH), observed in a subset of MS patients and thought
to represent axonal damage, show moderate to strong correlation with disability. The pathogenesis of T1BH remains
unclear. We previously reported the first and as of yet only model of T1BH formation in the Theiler’s murine encephalitis
virus induced model of acute CNS neuroinflammation induced injury, where CD8 T-cells are critical mediators of axonal
damage and related T1BH formation. The purpose of this study was to further analyze the role of CD8 and CD4 T-cells
through adoptive transfer experiments and to determine if the relevant CD8 T-cells are classic epitope specific lymphocytes
or different subsets. C57BL/6 mice were used as donors and RAG-1 deficient mice as hosts in our adoptive transfer
experiments. In vivo 3-dimensional MRI images were acquired using a 7 Tesla small animal MRI system. For image analysis,
we used semi-automated methods in Analyze 9.1; transfer efficiency was monitored using FACS of brain infiltrating
lymphocytes. Using a peptide depletion method, we demonstrated that the majority of CD8 T-cells are classic epitope
specific cytotoxic cells. CD8 T-cell transfer successfully restored the immune system’s capability to mediate T1BH formation
in animals that lack adaptive immune system, whereas CD4 T-cell transfer results in an attenuated phenotype with
significantly less T1BH formation. These findings demonstrate contrasting roles for these cell types, with additional evidence
for a direct pathogenic role of CD8 T-cells in our model of T1 black hole formation.
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Introduction
Multiple sclerosis is the leading cause of disability among young
adults in the western world [1]. MRI findings in MS represent
important components of the diagnostic criteria and are
extensively used in clinical disease monitoring [2]. In general,
T2 hyperintense lesion-based MRI features in MS ,including
lesion load or number of lesions, show only a limited correlation
with neurological outcome and future disability risk; however, the
presence of chronic lesional T1 hypointensity or T1 black holes
(T1BH) is associated with a more disabling course [3,4]. T1BH is
thought to represent axonal damage [5,6]. The exact pathomech-
anism leading to the formation of T1BH remains poorly
understood due to the lack of appropriate experimental model
systems and inability to mechanistically address this issue in
clinical research.
TMEV infection in mice is an accepted model of multiple
sclerosis [7,8]. In this model, mice of susceptible genetic
background develop a biphasic disease; the late or chronic phase
is characterized by chronic-progressive demyelination. In contrast
to the most commonly used experimental allergic encephalomy-
elitis (EAE) models, the initial target of the immune response in the
TMEV models is the viral infection itself; however, in later stages
of the disease, the immune response also includes myelin self-
epitopes via epitope spread [9]. C57BL/6 mice, infection with
Theiler’s Murine Encephalomyelitis Virus (TMEV) results in the
MRI phenomenon of T1BH formation [10]. It is important to
note that C57BL/6 mice represent a resistant strain, meaning that
chronic-progressive demyelination doesn’t develop in this model.
The observed T1 black holes appear in the context of acute
neuroinflammation in the early stage of viral infection; however,
axonal damage, the most specific and pathognomonic process that
characterizes T1 black holes in MS, is also observed in these areas
in our model [10,11]. Similarly to the original observations in MS,
tissue studies in our model demonstrate extensive axonal and
neuronal damage in these areas [12]. As demonstrated by our
team earlier, CD8 T- cells are the main contributors in the
pathogenesis of T1 hypointense lesions in this model [10]. CD8 T-
cells have also been associated with axonal injury in the TMEV
model [13,14,15,16,17], contribute to the development of
autoimmune responses in this model [18] and also play a critical
role in inducing severe blood-brain barrier permeability under
specific conditions [19,20,21,22].
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considered the most significant mediators in the pathogenesis of
MS and its key animal model, EAE (experimental allergic
encephalomyelitis) [23]. While subsets of CD 4 T cells are
common targets in therapeutic efforts directed at MS, recent
pathology reports also indicate an important role for CD8 T cells.
CD8 T cells are the most numerous lymphocyte subpopulations in
MS lesions and in normal appearing MS tissue, regardless of MS
subtype or stage of lesion formation [15,24]. CD8 T-cells were also
observed in close proximity to damaged neurons in axons both in
MS and our model [15,25]. Despite these observations, the role of
CD8 T-cells remains controversial, as some studies suggest that
CD8 T-cells are mainly regulators and suppressors of the
inflammatory activity. [15,24] Therefore, the contribution of
CD8 T cells in MS pathogenesis in the form of axonal disruption
and new lesion formation needs to be further defined.
Our current study had two main goals: (1) to establish whether the
pathogenic CD8 T-cells in our model are classic viral epitope
specific cytotoxic lymphocytes or other CD8+ immune cell types,
and (2) to investigate the potential role of CD4 T cells in the
process of T1BH formation.
In our experiments, we utilized transgenic mice with no
adaptive immune system (RAG-1
2/2 mice). We adoptively
transferred CD8+ or CD4+ cells from donor C57BL/6 mice into
RAG-1
2/2 mice [25]. These experiments were designed to
demonstrate if the immune system’s capability to generate T1BH
can be restored by the above cell transfers. In a separate
experiment, we utilized a peptide depletion technology to
selectively eliminate CD8 T-cells recognizing the immunodomi-
nant peptide in our model [26]. We know from previous
experiments in this model that over 70% of brain infiltrating
CD8 T-cells recognize a specific viral capsid peptide, VP2121–130
[26,27,28]. By intravenously injecting this peptide one day prior to
disease induction with TMEV, we can effectively eliminate CD8
T-cells that recognize this peptide [26,27].
Our experiments demonstrate a surprising contrast in the
contribution by CD8 vs. CD4 T-cells in T1BH formation, and
confirmed that T1BH formation is driven mainly by epitope
specific CD8 T-cells in our model.
Materials and Methods
Mice
C57BL/6J and RAG-1 deficient mice on C57BL/6 background
were purchased from the Jackson Laboratory in Bar Harbor, ME.
The number of mice used is as detailed below. The experiments
were approved by the local Institutional Animal Care and Use
Committee at the University of Cincinnati (06-10-09-01) and at
Mayo Clinic, Rochester, Minnesota (A29509). TMEV infection
using the Daniels strain was induced via intracerebral inoculation
of 200,000 PFU using standard methods described earlier
[29,30,31].
Peptide depletion experiment
In the experiments determining whether VP2 epitope specific
CD8 T-cells contribute to the process of T1BH formation, we used
epitope depletion by intravenous administration of VP2121–130
peptide one day prior to TMEV infection, as described in details
earlier [27]. In this study, 8 TMEV infected mice underwent VP2
depletion, and 8 TMEV infected mice received irrelevant E7
peptide injection as negative controls. The E7 peptide is derived
from the human papilloma virus, which has no relevance to
TMEV infection [27].
Isolation of Brain Lymphocytes
As published by our team earlier [12], whole brains were strained
through a nylon mesh 100-mm filter into RPMI (MediaTech Inc.,
Herndon, VA), and 700 mg of collagenase type 4 (Worthington,
Lakewood, NJ) was added to each 5-ml tissue suspension.
Suspensions wereincubated in a water bath at 42uC for 45 minutes.
Each 5-ml suspension was then added to 50 ml high speed
centrifuge tubes (Nalge Nunc International, Rochester, NY)
containing a solution of 1 ml of 106PBS, 9 ml of Percoll (Sigma-
Aldrich GmbH, Steinheim, Germany), and 35 ml of RPMI. Cell
suspensions were then spun at 10,000 rpm (Sorvall SS-34 rotor) for
30 minutes (6g max=11962.6). The lymphocyte layer present in
the bottom 5 ml of solution was collected. This lymphocyte layer
was then suspended into 50 ml conical tubes (Becton Dickinson,
Franklin Lakes, NJ) and diluted with RPMI to a total volume of
50 ml.Cell suspensions were then spun at3006g for10 minuteson
a Sorvall Legend RT tabletop centrifuge. Media was aspirated off,
and cell pellets were resuspended in RPMI media.
FACS analysis
Isolated brain lymphocytes were resuspended in FACS buffer
(16PBS, 1% FCS and 0.025% sodium azide) and incubated with
Db:VP2
121–130 tetramer or Db:E7 tetramer for 40 minutes
followed by a 20 minute incubation with anti-CD4 and anti-
CD8. Cells were then rinsed twice with FACS buffer and fixed in
1% PFA in 16 PBS. Samples were run on a BD LSR II flow
cytometer (BD Biosciences, San Jose CA) and analyzed using
FACS Diva software (BD Biosciences, San Jose CA).
Studies of viral load
We performed plaque assays to determine viral load using
established methods [32,33]. Briefly, 7-day TMEV infected
brains were collected in Dulbecco’s medium and frozen at
280uC. We studied 3 brains per group. The brains were then
thawed, homogenized, and sonicated using two 90 second pulses.
This solution was then centrifuged at 2000 rpm for 10 minutes
and the supernatant was removed.
The plaque assays were performed using 10-fold dilutions of
brain homogenate. The serial dilutions aliquots were inoculated
onto susceptible L2 cell monolayers. Each dilution is plated in
duplicate to enhance accuracy. L2 cells were plated at a density of
1610
5/well in 12-well plates the day before. The cells were
incubated at 37uC for 1 h before the addition of 1 ml of DMEM
containing 2% FBS and 0.5% low-melting-point agarose. When
the plates are incubated, the original infected cells release viral
progeny. Viral spread is restricted to neighboring cells by the gel.
Consequently, each infectious particle produces a circular zone of
infected cells called a plaque. Eventually the plaque becomes large
enough to be visible to the naked eye. After 72 h at 37uC, the cells
were fixed and stained with cresyl violet to enhance the contrast
between the living cells and the plaques.
Viral titers were calculated in plaque-forming units (PFU) per
milliliter. To determine the virus titer, the plaques are counted at
the lowest dilution that forms plaques in the plate wells. To
calculate the titer of virus the plagues from the lowest dilution to
form plaques were counted. The duplicates for each dilution were
counted and averaged. The average was then multiplied by 50 and
the dilution factor that was counted. The resulting number is the
PFU per well.
Adoptive transfer experiments
To determine the role of CD8 and CD4 T cells in general, we
utilized mice that lack an adaptive immune system, and as such,
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2/2 mice
otherwise have the same genetic background as C57BL/6 mice.
We harvested CD8 and CD 4 T cells from spleens of C57BL/6
mice, and transferred these into irradiated RAG-1 2/2 recipient
mice as described earlier [25]. Briefly, spleens of GFP+ mice
(C57BL/6-Tg(UBC-GFP)30Scha/J mice, # 004353, The Jackson
Laboratory, Bar Harbor, ME) were removed and strained through
a nylon mesh 100-mm filter. CD8+ and CD4+ cells were purified
from the resulting lymphocyte population using MACS LS cell
purification columns (Miltenyi Biotec, Auburn, CA) according to
the manufacturer’s protocol, resulting in 95% purity as determined
by flow cytometric analysis (data not shown). C57BL/6 mice were
irradiated with 400 rads of c-radiation then received 10
6 CD8+ or
CD4+ positively sorted spleen cells via tail-vein injection. Positive
sorting does not affect functions of CD4 or CD8 T cells.
MRI acquisition and analysis
In each case, the formation of T1BH was monitored by
volumetric MRI: a volume acquisition T1BH-s were defined as
focal cerebral hypointensity as demonstrated by our team earlier
[10]. T1 weighted spin echo sequence was used, with 200 mm
isometric resolution using a Bruker Biospec 7 Tesla horizontal bore
small animal MRI system, on day 7 following disease induction with
TMEV, as described earlier [10,34]. We utilize standard spin echo
sequences to conform with the original study demonstrating T1BH
in MS [3]. For volumetric analysis, the 3D ROI tool was used in
Analyze 9.1 (Mayo Clinic, Biomedical Imaging Resource) [35,36].
Since the analysis is semi-automated, we needed to standardize the
analysis methods and use 2 investigators to analyze each dataset at
least twice. Their intra-and inter-rater reliability was superior, as
reported earlier [37]. The outcome analyzed in our studies was the
total volume of T1BH per animal.
Results
Adoptive cell transfer experiments
T1BH-s were observed in all TMEV infected experimental
groups (Figure 1). The cell transfer experiments revealed that CD8
T cell recipient mice developed an average T1BH volume over 3
fold higher compared to sham transfer controls (p=0.0002)
(Figure 2). The detected total T1BH volumes per animal were
comparable to our original findings in C57B6/J mice [10]. In
sharp contrast, our CD4 transfer experiments demonstrated a
surprising finding: CD4 T cells actively inhibited T1BH formation
in our model. An almost 4-fold reduction was detected (p=0.0006)
in T1BH volume compared to sham treated irradiated infected
controls. The observed low-level T1BH formation among
recipients of sham transfer is thought to be mediated either by
innate immune cells, most likely neutrophils, microglia or
macrophages; or via direct viral cytopathic effects. These
alternative mechanisms are also the subject of ongoing investiga-
tions in our laboratory. We did not perform CD4 or CD8 transfers
to uninfected hosts, as homing of immune cells in that condition is
not expected.
FACS analysis of brain infiltrating lymphocytes
Following the MRI acquisition experiments, the animals were
sacrificed on the same day and their brains were extracted for flow
cytometric analysis of brain infiltrating lymphocyte subsets.
(Figure 3.) We were specifically interested in transfer efficacy,
and in the proportion of CD8 T-cells recognizing VP2 epitopes. In
brains with sham transfer, 1.6% of cells were CD8+ positive vs. in
brains with CD8 splenocyte transfer, were 12.6% positivity was
demonstrated (Figure 2A). Using tetramer technology, we
demonstrated that a total of 2.6% of CD8+ cells were also VP2
121–130 specific.
CD4 transfer was also monitored by FACS (Figure 3B). 14.4%
of brain infiltrating immune cells were CD4+ and CD82
following CD4+ splenocyte transfer; whereas only 0.2% were
CD4+ CD82 after sham transfer.
Viral load analysis
To determine whether differences in viral load may explain the
observed differences in T1BH volume between our CD8 and CD4
adoptive transfer groups, we performed plaque assays. These
assays revealed that there was no significant difference (p=0.62) in
Figure 1. Example for T1 black hole formation in 7-day TMEV infected C57BL/6J mice. Top row: axial images, bottom row: coronal images
extracted from a representative mouse. To provide guidance, some (but not all) areas containing T1 black holes are indicated with red frames. These
are located in diverse areas of the brain, but mostly in periventricular areas, in the thalamus, hippocampus, white matter, corpus callosum and even in
the cortex.
doi:10.1371/journal.pone.0031459.g001
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deficient mice on day 7 of TMEV infection (Figure 4).
Epitope specific CD8 T-cell depletion experiments
Depleting the CD8 T cells that recognize the VP2 immunodo-
minant peptide (Figure 5) resulted in a significant 2-fold reduction
of T1BH formation compared to sham treatment with E7 peptide
(p=0.017). This suggests that the vast majority of CD8 T-cells
contributing to T1BH formation are classic epitope specific
cytotoxic lymphocytes.
Discussion
The above results reinforce that CD8 T cells play the
predominant role in the pathogenesis of T1BH formation, and
clarifies that the leading contribution in this process is by
epitope specific cytotoxic CD8 T cells. Since a small degree of
T1BH formation is observed even in control animals (infected
RAG-1 2/2 mice receiving sham transfer) it is likely that either
direct cytopathic effects or cells of the innate immune system,
likely neutrophils, also contribute to this process. Meanwhile,
when CD4 cells are transferred to animals with deficient adaptive
immunity, they appear to play a preventive role in T1BH
formation and significantly reduce the observed baseline T1BH
formation.
T1BH-s are thought to represent axonal and/or neuronal
damage in MS [6,38,39]. In the TMEV model, viral replication
mostly takes place in neurons in the stage when our experiments
were conducted [40,41], and at this stage and in this strain,
demyelination is not observed, unless stimulated by the intrave-
nous injection of the immunodominant VP2 peptide, as
demonstrated by our team earlier [19,42]. We therefore
hypothesize that cytotoxic CD8 T cells targeting the immunodo-
minant VP2 epitope are targeting neurons and axons, consistent
with our recent published studies [12]. By transferring CD8 T-cells
into CD8 deficient infected hosts, we were able to restore T1BH
formation. In addition epitope specific elimination of VP2 specific
CD8 T-cells resulted in reduced T1BH formation. Altogether,
these observations very strongly suggest that T1BH formation in
this model is related to neuronal and axonal injury caused directly
or indirectly by CD8 T-cells. Given that CD8 T-cells are the most
numerous lymphocytes in MS lesions regardless of stage of lesion
formation, and given that CD8 T-cells have been observed
strongly apposed to neurons and axons in MS tissue, we propose
that a similar CD8 T cell driven mechanism as observed in our
model may be responsible for T1BH formation in MS [43,44].
Another key analogy between our model and MS-related T1BH
Figure 2. MRI T1BH volumetry results in adoptive transfer experiments using RAG 1 2/2 recipient mice. The bar chart shows the mean
T1BH volumes in CD8 and CD4 adoptive transfer experiments. Controls represent sham transfer (PBS injection) following irradiation and infection.
CD8 T cell transfer resulted in 3-fold increase of T1BH formation, while CD4 transfer resulted in a 2-fold decrease. Error bars represent SD.
doi:10.1371/journal.pone.0031459.g002
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efficiency following adoptive transfer of CD8+ splenocytes from C57BL/6 donors into RAG-1 deficient hosts. Note that with sham transfer, only 1.6%
of BIL-s is CD8+ and only 0.2% recognizes VP2 epitopes, whereas transfer of CD8+ cells results in 12.6% CD8+ positivity and 2.6% positivity for VP2
peptide. The 3.3% VP2+ CD82 cells are overall unidentified, and potentially represent dead cells that bind tetramer, auto fluorescing CNS cells, dying
CD8+ tetramer+ cells that have become CD82 tetramer+, or NK cells with receptors specific for class I. Figure 3B (lower half) describes transfer
efficiency in our CD4 transfer experiments. With sham transfer, only 0.2% of BIL-s is CD4+, whereas with CD4 transfer, 14.4% positivity is
demonstrated.
doi:10.1371/journal.pone.0031459.g003
Figure 4. Differences in viral load. We measured TMEV viral load on day 7 following TMEV infection of RAG-1 deficient mice that underwent
adoptive transfer of CD4 or CD8 T-cells, respectively. Overall, the viral loads aren’t different (p=0.62) between the two groups, demonstrating that
the observed T1BH formation isn’t directly related to viral load.
doi:10.1371/journal.pone.0031459.g004
CD4 vs CD8 T-Cells in T1 Black Hole Formation
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main tissue damage captured by this MRI finding, which is further
underlined by the fact that demyelination is absent at this stage
and in this strain in our model. [3,5,45]
The surprising protective role of CD4 T cells may be explained
by previously published findings related to CD4 T-cell biology in
TMEV infection. CD4 T-cells can play both protective and
pathogenic roles in TMEV infection. During the acute neuroin-
flammatory stage of TMEV infection, CD4+ Th1 T-cells appear
to control the viral infection [46,47], although we did not notice
significant differences in viral load in our experiment in day 7;
therefore the observed protective role is unlikely to be related to
this effect. Furthermore, experimental neutralization of a classic
CD4 T-cell cytokine, IFN-c, resulted in significantly accelerated
disease onset [48]. IFN-gamma was also demonstrated to play a
critical role in protecting spinal cord neurons from persistent
TMEV infection and death [49]. On the other hand, these cells
also play a pathogenic role in the chronic stages of TMEV
infection of susceptible mice, where neutralization of IL-12, a
classic CD4 Th1 cytokine, resulted in an attenuated disease
phenotype with decreased demyelination [50]. CD4 T-cells with a
Th2 phenotype have been proposed to overall suppress inflam-
mation and demyelination: IL-4 treatment during the early
chronic phase of TMEV infection resulted in a more benign
disease phenotype, with reduced anti-TMEV antibody responses
[51]. However, this observation is not applicable to our
experimental system for two reasons: one, the utilized RAG-1
deficient mice are unable to mount an antibody response; two, we
are studying the acute neuroinflammatory stage of TMEV
infection. Overall, in the classic TMEV induced biphasic MS
models, it remains unclear whether Th2 cytokines play a
protective (suppression of pathogenic CD4 Th1 cells) or
pathogenic role (by increasing antibody production) in demyelin-
ating disease [52].
A recent novel observation suggests that Th17 cells, a subset of
CD4 T cells prolong neuronal survival in the TMEV model in
vitro [53]. Such neuroprotective effect may also have contributed
to the observed attenuated MRI phenotype in our study. In
addition, Th17 mediated suppression of CTL function was also
observed in TMEV infection, which may also theoretically lead to
reduced T1BH formation, but not in our model system, as
endogenous CD8 T-cells are not present in our host mice.
In the TMEV model, BALB/cByJ mice are resistent while
BALB/cAnNCr mice are susceptible to the development of
chronic demyelination. The susceptibility of BALB/cAnNCr mice
is thought to be directly caused by a defective/absent CD4+ T-cell
subset, providing another example how CD4+ T-cells may
regulate the overall phenotype observed in this model, acting in
the earliest, most acute stage immediately after infection [54].
We constantly observe low level but clearly detectable T1BH
formation in RAG-1 deficient mice (Figure 2) [10]. We therefore
suspect that cells of innate immunity, likely neutrophils, macro-
phages or microglia may contribute to axonal/neuronal damage
and resultant T1BH formation, which is an active area of research
in our laboratory. We also hypothesize that the presence of CD4
T-cells in our adaptive transfer model may result in the
attenuation of this innate immune response leading to the
observed reduction in T1BH formation. The exact mechanism
for the above is to be determined in ongoing and future
experiments in our laboratory.
In conclusion, these findings demonstrate a contrasting role for
CD4 vs. CD8 cells in T1BH formation in the TMEV model of
MS. Further investigations in our model will clarify the role and
significance of CD8 T-cells in axonal and neuronal damage, and
the role of CD4 T-cells in the observed protective process.
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Figure 5. MRI T1BH volumetry results following peptide depletion. VP2 is the viral epitope recognized by over 75% of all CNS infiltrating
CD8 T cells in the context of TMEV infection of C57BL6/J mice. E7 is an irrelevant viral petide. Note the significant reduction in T1BH formation by
peptide-induced depletion (injection of VP2 peptide 1 day prior to infection). Y axis: volume units in 0.01 mm
3. Error bars represent SD.
doi:10.1371/journal.pone.0031459.g005
CD4 vs CD8 T-Cells in T1 Black Hole Formation
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31459References
1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple
sclerosis. N Engl J Med 343: 938–952.
2. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005)
Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘‘McDonald
Criteria’’. Ann Neurol 58: 840–846.
3. van Walderveen MA, Barkhof F, Hommes OR, Polman CH, Tobi H, et al.
(1995) Correlating MRI and clinical disease activity in multiple sclerosis:
relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo
images. Neurology 45: 1684–1690.
4. Truyen L, van Waesberghe JH, van Walderveen MA, van Oosten BW,
Polman CH, et al. (1996) Accumulation of hypointense lesions (‘‘black holes’’) on
T1 spin-echo MRI correlates with disease progression in multiple sclerosis.
Neurology 47: 1469–1476.
5. van Walderveen MA, Kamphorst W, Scheltens P, van Waesberghe JH, Ravid R,
et al. (1998) Histopathologic correlate of hypointense lesions on T1-weighted
spin-echo MRI in multiple sclerosis. Neurology 50: 1282–1288.
6. Barkhof F, Karas GB, van Walderveen MA (2000) T1 hypointensities and
axonal loss. Neuroimaging Clin N Am 10: 739–752, ix.
7. Brahic M (2002) Theiler’s virus infection of the mouse, or: of the importance of
studying animal models. Virology 301: 1–5.
8. Denic A, Johnson AJ, Bieber AJ, Warrington AE, Rodriguez M, et al. (2011)
The relevance of animal models in multiple sclerosis research. Pathophysiology
18: 21–29.
9. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, et al. (1997)
Persistent infection with Theiler’s virus leads to CNS autoimmunity via epitope
spreading. Nat Med 3: 1133–1136.
10. Pirko I, Nolan TK, Holland SK, Johnson AJ (2008) Multiple sclerosis:
pathogenesis and MR imaging features of T1 hypointensities in a [corrected]
murine model. Radiology 246: 790–795.
11. McDole JR, Danzer SC, Pun RY, Chen Y, Johnson HL, et al. (2010) Rapid
Formation of Extended Processes and Engagement of Theiler’s Virus-Infected
Neurons by CNS-Infiltrating CD8 T Cells. Am J Pathol.
12. McDole JR, Danzer SC, Pun RY, Chen Y, Johnson HL, et al. (2010) Rapid
formation of extended processes and engagement of Theiler’s virus-infected
neurons by CNS-infiltrating CD8 T cells. Am J Pathol 177: 1823–1833.
13. Deb C, Lafrance-Corey RG, Schmalstieg WF, Sauer BM, Wang H, et al. (2010)
CD8+ T cells cause disability and axon loss in a mouse model of multiple
sclerosis. PLoS ONE 5: e12478.
14. Howe CL, Ure D, Adelson JD, LaFrance-Corey R, Johnson A, et al. (2007)
CD8+ T cells directed against a viral peptide contribute to loss of motor function
by disrupting axonal transport in a viral model of fulminant demyelination.
J Neuroimmunol 188: 13–21.
15. McDole J, Johnson AJ, Pirko I (2006) The role of CD8+ T-cells in lesion
formation and axonal dysfunction in multiple sclerosis. Neurol Res 28: 256–261.
16. Tsunoda I, Kuang LQ, Kobayashi-Warren M, Fujinami RS (2005) Central
nervous system pathology caused by autoreactive CD8+ T-cell clones following
virus infection. J Virol 79: 14640–14646.
17. Myoung J, Hou W, Kang B, Lyman MA, Kang JA, et al. (2007) The
immunodominant CD8+ T cell epitope region of Theiler’s virus in resistant
C57BL/6 mice is critical for anti-viral immune responses, viral persistence, and
binding to the host cells. Virology 360: 159–171.
18. Tsunoda I, Kuang LQ, Fujinami RS (2002) Induction of autoreactive CD8+
cytotoxic T cells during Theiler’s murine encephalomyelitis virus infection:
implications for autoimmunity. J Virol 76: 12834–12844.
19. Pirko I, Suidan GL, Rodriguez M, Johnson AJ (2008) Acute hemorrhagic
demyelination in a murine model of multiple sclerosis. J Neuroinflammation 5:
31.
20. Suidan GL, Dickerson JW, Chen Y, McDole JR, Tripathi P, et al. (2010) CD8 T
cell-initiated vascular endothelial growth factor expression promotes central
nervous system vascular permeability under neuroinflammatory conditions.
J Immunol 184: 1031–1040.
21. Suidan GL, McDole JR, Chen Y, Pirko I, Johnson AJ (2008) Induction of blood
brain barrier tight junction protein alterations by CD8 T cells. PLoS ONE 3:
e3037.
22. Suidan GL, Pirko I, Johnson AJ (2006) A potential role for CD8+ T-cells as
regulators of CNS vascular permeability. Neurol Res 28: 250–255.
23. Chitnis T (2007) The role of CD4 T cells in the pathogenesis of multiple
sclerosis. Int Rev Neurobiol 79: 43–72.
24. Johnson AJ, Suidan GL, McDole J, Pirko I (2007) The CD8 T cell in multiple
sclerosis: suppressor cell or mediator of neuropathology? Int Rev Neurobiol 79:
73–97.
25. McDole JR, Danzer SC, Pun RY, Chen Y, Johnson HL, et al. (2010) Rapid
formation of extended processes and engagement of Theiler’s virus-infected
neurons by CNS-infiltrating CD8 T cells. Am J Pathol 177: 1823–1833.
26. Johnson AJ, Njenga MK, Hansen MJ, Kuhns ST, Chen L, et al. (1999)
Prevalent class I-restricted T-cell response to the Theiler’s virus epitope
Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor
alpha, gamma interferon, perforin, or costimulation through CD28. J Virol 73:
3702–3708.
27. Johnson AJ, Upshaw J, Pavelko KD, Rodriguez M, Pease LR (2001)
Preservation of motor function by inhibition of CD8+ virus peptide-specific T
cells in Theiler’s virus infection. Faseb J 15: 2760–2762.
28. Kang HS, Kim BS (2010) Predominant clonal accumulation of CD8+ T cells
with moderate avidity in the central nervous systems of Theiler’s virus-infected
C57BL/6 mice. J Virol 84: 2774–2786.
29. Pirko I, Gamez J, Johnson AJ, Macura SI, Rodriguez M (2004) Dynamics of
MRI lesion development in an animal model of viral-induced acute progressive
CNS demyelination. Neuroimage 21: 576–582.
30. Denic A, Johnson AJ, Bieber AJ, Warrington AE, Rodriguez M, et al. (2011)
The relevance of animal models in multiple sclerosis research. Pathophysiology
18: 21–29.
31. Pirko I, Johnson AJ, Lohrey AK, Chen Y, Ying J (2009) Deep gray matter T2
hypointensity correlates with disability in a murine model of MS. J Neurol Sci.
32. Kerkvliet J, Zoecklein L, Papke L, Denic A, Bieber AJ, et al. (2009) Transgenic
expression of the 3D polymerase inhibits Theiler’s virus infection and
demyelination. J Virol 83: 12279–12289.
33. Pavelko KD, Girtman MA, Mitsunaga Y, Mendez-Fernandez YV, Bell MP,
et al. (2011) Theiler’s murine encephalomyelitis virus as a vaccine candidate for
immunotherapy. PLoS ONE 6: e20217.
34. Denic A, Macura SI, Mishra P, Gamez JD, Rodriguez M, et al. (2011) MRI in
rodent models of brain disorders. Neurotherapeutics 8: 3–18.
35. Robb RA (1999) 3-D visualization in biomedical applications. Annu Rev
Biomed Eng 1: 377–399.
36. Robb RA (2001) The biomedical imaging resource at Mayo Clinic. IEEE Trans
Med Imaging 20: 854–867.
37. Pirko I, Johnson AJ, Chen Y, Lindquist DM, Lohrey AK, et al. (2011) Brain
atrophy correlates with functional outcome in a murine model of multiple
sclerosis. Neuroimage 54: 802–806.
38. Losseff NA, Wang L, Miller DH, Thompson AJ (2001) T1 hypointensity of the
spinal cord in multiple sclerosis. J Neurol 248: 517–521.
39. Pirko I, Nolan TK, Holland SK, Johnson AJ (2008) Multiple sclerosis:
pathogenesis and MR imaging features of T1 hypointensities in murine model.
Radiology 246: 790–795.
40. Sato F, Tanaka H, Hasanovic F, Tsunoda I (2010) Theiler’s virus infection:
Pathophysiology of demyelination and neurodegeneration. Pathophysiology.
41. Tsunoda I, Fujinami RS (2010) Neuropathogenesis of Theiler’s murine
encephalomyelitis virus infection, an animal model for multiple sclerosis.
J Neuroimmune Pharmacol 5: 355–369.
42. Johnson AJ, Mendez-Fernandez Y, Moyer AM, Sloma CR, Pirko I, et al. (2005)
Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome.
J Immunol 174: 6854–6862.
43. Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti C, et al. (2001)
A longitudinal MRi study of histopathologically defined hypointense multiple
sclerosis lesions. Ann Neurol 49: 793–796.
44. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Bruck W (2000) Acute
axonal injury in multiple sclerosis. Correlation with demyelination and
inflammation. Brain 123(Pt 6): 1174–1183.
45. van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA,
Castelijns JA, et al. (1999) Axonal loss in multiple sclerosis lesions: magnetic
resonance imaging insights into substrates of disability. Ann Neurol 46: 747–754.
46. Borrow P, Welsh CJ, Nash AA (1993) Study of the mechanisms by which CD4+
T cells contribute to protection in Theiler’s murine encephalomyelitis.
Immunology 80: 502–506.
47. Chang JR, Zaczynska E, Katsetos CD, Platsoucas CD, Oleszak EL (2000)
Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of
Theiler’s murine encephalomyelitis virus-infected susceptible and resistant
strains of mice. Virology 278: 346–360.
48. Pullen LC, Miller SD, Dal Canto MC, Van der Meide PH, Kim BS (1994)
Alteration in the level of interferon-gamma results in acceleration of Theiler’s
virus-induced demyelinating disease. J Neuroimmunol 55: 143–152.
49. Rodriguez M, Zoecklein LJ, Howe CL, Pavelko KD, Gamez JD, et al. (2003)
Gamma interferon is critical for neuronal viral clearance and protection in a
susceptible mouse strain following early intracranial Theiler’s murine enceph-
alomyelitis virus infection. J Virol 77: 12252–12265.
50. Inoue A, Koh CS, Yamazaki M, Yahikozawa H, Ichikawa M, et al. (1998)
Suppressive effect on Theiler’s murine encephalomyelitis virus-induced demy-
elinating disease by the administration of anti-IL-12 antibody. J Immunol 161:
5586–5593.
51. Hill KE, Pigmans M, Fujinami RS, Rose JW (1998) Gender variations in early
Theiler’s virus induced demyelinating disease: differential susceptibility and
effects of IL-4, IL-10 and combined IL-4 with IL-10. J Neuroimmunol 85:
44–51.
52. Yamada M, Zurbriggen A, Fujinami RS (1990) Monoclonal antibody to
Theiler’s murine encephalomyelitis virus defines a determinant on myelin and
oligodendrocytes, and augments demyelination in experimental allergic
encephalomyelitis. J Exp Med 171: 1893–1907.
53. Hou W, Kang HS, Kim BS (2009) Th17 cells enhance viral persistence and
inhibit T cell cytotoxicity in a model of chronic virus infection. J Exp Med 206:
313–328.
54. Karls KA, Denton PW, Melvold RW (2002) Susceptibility to Theiler’s murine
encephalomyelitis virus-induced demyelinating disease in BALB/cAnNCr mice
is related to absence of a CD4+ T-cell subset. Mult Scler 8: 469–474.
CD4 vs CD8 T-Cells in T1 Black Hole Formation
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e31459